| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |